Texas Rangers and Seattle Mariners meet in game 2 of series
Sep 27, 2022, 11:41 AM | Updated: Sep 28, 2022, 12:02 am
Texas Rangers (66-87, fourth in the AL West) vs. Seattle Mariners (83-70, second in the AL West)
Seattle; Wednesday, 9:40 p.m. EDT
PITCHING PROBABLES: Rangers: Martin Perez (12-6, 2.90 ERA, 1.25 WHIP, 164 strikeouts); Mariners: George Kirby (0-0, 19.29 ERA, 4.29 WHIP, one strikeout)
FANDUEL SPORTSBOOK LINE: Mariners -160, Rangers +140; over/under is 7 runs
BOTTOM LINE: The Texas Rangers play the Seattle Mariners with a 1-0 series lead.
Seattle has a 39-33 record at home and an 83-70 record overall. The Mariners have the fifth-ranked team ERA in the AL at 3.57.
Texas is 66-87 overall and 34-42 on the road. The Rangers are 43-18 in games when they scored five or more runs.
The matchup Wednesday is the 18th time these teams square off this season. The Mariners have a 12-5 advantage in the season series.
TOP PERFORMERS: J.P. Crawford has 24 doubles, three triples, six home runs and 41 RBI for the Mariners. Carlos Santana is 6-for-38 with two doubles and two home runs over the last 10 games.
Marcus Semien has 31 doubles, five triples and 24 home runs for the Rangers. Corey Seager is 10-for-39 with four doubles, two home runs and six RBI over the last 10 games.
LAST 10 GAMES: Mariners: 3-7, .215 batting average, 4.93 ERA, outscored by six runs
Rangers: 4-6, .219 batting average, 3.99 ERA, outscored by seven runs
INJURIES: Mariners: Julio Rodriguez: 10-Day IL (back), Ryan Borucki: 15-Day IL (forearm), Tom Murphy: 60-Day IL (shoulder), Casey Sadler: 60-Day IL (shoulder)
Rangers: Corey Seager: day-to-day (arm), Brett Martin: 15-Day IL (shoulder), Dane Dunning: 15-Day IL (hip), Nick Solak: 60-Day IL (foot), Brad Miller: 60-Day IL (hip), Josh Sborz: 60-Day IL (elbow), Spencer Howard: 15-Day IL (shoulder), Mitch Garver: 60-Day IL (forearm), Eli White: 60-Day IL (wrist)
___
The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
